AKAN
Akanda Corp
NASDAQ: AKAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.99
+48.60% today
Updated 2026-04-29
Market cap
$13.89M
P/E ratio
0.04
P/S ratio
16.60x
EPS (TTM)
$696.80
Dividend yield
—
52W range
$2 – $121
Volume
2.1M
Akanda Corp (AKAN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$25.99
12-Month target
$1.55
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.04x (capped 25x) · Margin: -266.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.